Company / Total Assets
Vera Therapeutics, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$734.7M
FY2025
5-year range
$83.7M / $734.7M
FY2021-FY2025
Trend
+12.1%
vs FY2024
Sector context
#105 of 214
Health Care
What the data says
At $735M, Vera Therapeutics, Inc.'s total assets ranks #105 of 214 in the Health Care sector. Total Assets has increased for 5 consecutive years, from $55M in FY2020 to $735M in FY2025.
Based on SEC 10-K filings.
$735M in FY2025 with a 5-year CAGR of +68.2%.
Improved from $176M to $735M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +77.5%
- 5-Year CAGR
- +68.2%
- 10-Year CAGR
- -
Sector benchmark
#105 of 214 in Health CareTop 49% of 214This company $734.7M Sector average $7.5B
▼
-90.2% below sector average
Key checks
Key Insights
- Vera Therapeutics, Inc.'s total assets has grown for 5 consecutive years.
- 5-year CAGR of +68.2%, indicating consistent growth.
- In FY2025, total assets increased 12.1% year-over-year.
- Ranks #105 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $734.7M | +12.1% |
| FY2024 | $655.7M | +273.5% |
| FY2023 | $175.5M | +33.6% |
| FY2022 | $131.4M | +56.9% |
| FY2021 | $83.7M | +53.5% |
| FY2020 | $54.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026